ARCHIVES

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

Lung Screening Study Ties Up Advisors, Board Sends It Back To NCI For Revision.

June 29, 2001

Ford To Resubmit Budget Slash Of $125 Million For NCI

January 3, 1975

Consensus Conference In Early Breast Cancer Planned For June

May 11, 1990

NCI Cooperative Groups Begin Trial Of Individualized Rx For Breast Cancer

May 26, 2006

Nutrition Program Announcement Lists Suggested Areas For Research

September 22, 1978

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

April 28, 2006